Your browser is no longer supported. Please, upgrade your browser.
Settings
PPH VanEck Vectors Pharmaceutical ETF daily Stock Chart
PPH [NASD]
VanEck Vectors Pharmaceutical ETF
Index- P/E- EPS (ttm)- Insider Own- Shs Outstand- Perf Week-0.39%
Market Cap- Forward P/E- EPS next Y- Insider Trans- Shs Float- Perf Month-3.67%
Income- PEG- EPS next Q- Inst Own- Short Float- Perf Quarter0.55%
Sales- P/S- EPS this Y- Inst Trans- Short Ratio- Perf Half Y11.74%
Book/sh- P/B- EPS next Y- ROA- Target Price- Perf Year9.04%
Cash/sh- P/C- EPS next 5Y- ROE- 52W Range46.90 - 68.02 Perf YTD-3.58%
Dividend1.07 P/FCF- EPS past 5Y- ROI- 52W High-9.03% Beta-
Dividend %1.73% Quick Ratio- Sales past 5Y- Gross Margin- 52W Low31.94% ATR0.86
Employees- Current Ratio- Sales Q/Q- Oper. Margin- RSI (14)44.04 Volatility1.14% 1.35%
OptionableYes Debt/Eq- EPS Q/Q- Profit Margin- Rel Volume0.23 Prev Close61.53
ShortableYes LT Debt/Eq- Earnings- Payout- Avg Volume44.86K Price61.88
Recom- SMA20-1.17% SMA50-2.56% SMA200-0.08% Volume10,299 Change0.57%
Aug-11-20 03:29PM  
May-22-20 07:46AM  
May-18-20 10:03AM  
Apr-09-20 10:10AM  
Feb-07-20 11:05AM  
Jan-22-20 01:00PM  
Dec-20-19 08:10AM  
Dec-05-19 03:34PM  
Nov-22-19 05:15PM  
Nov-08-19 08:00AM  
Nov-06-19 11:00AM  
Sep-30-19 06:04PM  
Sep-23-19 11:27AM  
Sep-09-19 02:09PM  
Aug-22-19 11:12AM  
Aug-07-19 10:59AM  
Jun-28-19 06:01PM  
Jun-26-19 11:00AM  
Jun-25-19 06:01PM  
May-14-19 05:40PM  
May-09-19 10:05AM  
Apr-30-19 12:59PM  
Mar-29-19 06:42PM  
Mar-21-19 07:56AM  
Feb-21-19 10:08AM  
Feb-07-19 11:15AM  
Jan-29-19 09:08AM  
Jan-07-19 09:27AM  
Dec-26-18 06:37PM  
Dec-14-18 09:28AM  
Dec-10-18 10:33AM  
Nov-16-18 05:52PM  
Oct-24-18 11:59AM  
Oct-17-18 11:48AM  
Oct-12-18 06:00AM  
Oct-09-18 11:39AM  
Sep-28-18 06:03PM  
Jul-03-18 03:19PM  
Jun-29-18 06:15PM  
Jun-04-18 10:38AM  
Apr-24-18 06:41AM  
Mar-29-18 05:58PM  
Jan-25-18 09:00AM  
07:31AM  
Jan-22-18 10:00AM  
07:34AM  
Jan-15-18 10:31AM  
Jan-10-18 12:03PM  
Jan-09-18 10:31AM  
Jan-08-18 07:33AM  
Jan-05-18 10:35AM  
Dec-26-17 06:15PM  
Nov-22-17 05:30PM  
Nov-14-17 02:35PM  
Oct-16-17 12:33PM  
Oct-02-17 12:35PM  
Sep-29-17 05:25PM  
Sep-20-17 10:36AM  
Sep-19-17 10:38AM  
Sep-14-17 07:39AM  
Sep-11-17 10:36AM  
07:36AM  
Sep-06-17 09:06AM  
Sep-05-17 07:37AM  
Sep-04-17 09:06AM  
Aug-31-17 12:34PM  
07:38AM  
Aug-30-17 07:36AM  
Aug-23-17 11:53AM  
09:53AM  
Aug-21-17 04:05PM  
Aug-17-17 07:37AM  
Aug-15-17 09:06AM  
Aug-14-17 10:25AM  
Aug-07-17 09:53AM  
Aug-01-17 11:21AM  
07:41AM  
Jul-31-17 06:05PM  
Jul-28-17 05:05PM  
Jul-27-17 07:44AM  
Jul-25-17 04:25PM  
Jul-24-17 01:05PM  
10:37AM  
Jul-17-17 10:39AM  
10:27AM  
Jul-11-17 09:07AM  
Jul-10-17 03:10PM  
07:39AM  
Jul-04-17 10:37AM  
07:36AM  
Jul-03-17 09:10AM  
Jun-30-17 05:27PM  
Jun-28-17 10:36AM  
Jun-21-17 09:08AM  
Jun-20-17 12:09PM  
Jun-08-17 09:06AM  
Jun-02-17 07:36AM  
Jun-01-17 10:37AM  
May-24-17 09:06AM  
May-18-17 09:07AM  
The investment seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the MVIS US Listed Pharmaceutical 25 Index. The fund normally invests at least 80% of its total assets in securities that comprise the fund's benchmark index. The index includes common stocks and depositary receipts of U.S. exchange-listed companies in the pharmaceutical industry. Such companies may include medium-capitalization companies and foreign companies that are listed on a U.S. exchange. It is non-diversified.